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Background: Chronic low grade inflammation is closely 
linked to type II diabetes, obesity, and atherosclerosis. 
Macrophages play a key role in the regulation of pro- or an-
ti-inflammatory actions at the lesion sites of disease. 
Components of cordyceps militaris, cordycepin and ad-
enosine, have been used for the modulation of inflammatory 
diseases. The effects of cordycepin in the modulation of mac-
rophages have yet to be elucidated. We investigated the ef-
fects of cordycepin and adenosine on the morphological 
changes of macrophages under the inflammatory condition 
of LPS and an anti-inflammatory condition involving high 
concentrations of adenosine. Methods: We confirmed the 
mRNA levels of the M1/M2 cytokine genes through RT-PCR 
and morphological change. Results: LPS-activated macro-
phages returned to their inactivated original shape, i.e., they 
looked like naïve macrophages, through the treatment with 
high concentrations of cordycepin (40 μg/ml). LPS and ad-
enosine activated macrophages also returned to their origi-
nal inactivated shapes after cordycepin treatment; however, 
at relatively higher levels of cordycepin than adenosine. This 
change did not occur with relatively low concentrations of 
cordycepin. Adenosine down-regulated the gene expression 
of M1 cytokines (IL-1β, TNF-α) and chemokines (CX3CR1, 
RANTES), as well as cordycepin. Additionally, M2 cytokines 
(IL-10, IL-1ra, TGF-β) were up-regulated by both cordycepin 
and adenosine. Conclusion: Based on these observations, 
both cordycepin and adenosine regulated the phenotypic 
switch on macrophages and suggested that cordycepin and 
adenosine may potentially be used as immunomodulatory 
agents in the treatment of inflammatory disease.
[Immune Network 2009;9(6):255-264]
INTRODUCTION
Most arthritis, diabetes, and heart disease sufferers are all too 
familiar with inflammation. Inflammation is the activation of 
the immune system in response to infection, irritation, or in-
jury and is characterized by an influx of white blood cells, 
redness, heat, swelling, pain, and dysfunction of the organs 
involved (1,2). Macrophages play a key role in the immune 
system  via  the  regulation  of  pro-inflammatory  and  anti-in-
flammatory actions at the lesion sites of disease. In injured 
tissues,  monocytes/macrophages  infiltrate  inflamed  tissues 
and play central roles (3). Mediators of theses event including 
pro-inflammatory cytokines and chemokines promote macro-
phage accumulation via increasing the expression of adhesion 
molecules (3,4). In these states, macrophages are called clas-
sically activated M1 macrophages (M1), and are induced by 
IFN-γ either alone or in concert with microbial stimuli (e.g. 
lipopolysaccharides  (LPS))  or  cytokines  (e.g.  TNF-α and 
GM-CSF) (5). Anti-inflammatory cytokines such as IL-4, IL-10, 
and IL-13 have been found to be more than simple inhibitors 
of macrophage activation, but also able to induce an alter-
native  M2  form  of  macrophage  activation  (M2)  (6).
    Taken  together,  macrophage  phenotype  is  an  important 
factor in recruiting macrophages to the lesion site, scavenging 
pathogens,  expressing  surface  proteins,  and  releasing  pro- 
and  anti-inflammatory  cytokines.
    Cordycepin, 3’-deoxyadenosine, is an effective component 
isolated from Cordyceps militaris. Cordycepin has various bi-Role of Cordycepin and Adenosine on the Phenotypic Switch of Macrophages
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ological effects including anti-fungal (7), anti-malarial (8), an-
ti-herpes (9), anti-tumorigenic on some cell lines, anti-leuke-
mic  activities  (10),  and  anti-diabetic  effects  (11).
    Adenosine  is  an  endogenous  purine  nucleoside  that,  fol-
lowing  its  release  from  cells  or  after  being  formed  ex-
t r a c e l l u l a r l y ,  d i f f u s e s  t o  t h e  c e l l  m e m b r a n e  o f  s u r r o u n d i n g  
cells where it binds specific cell-surface structures that recog-
nize it, termed adenosine receptors (12,13). The role of ad-
enosine as an extracellular signaling molecule demonstrated 
that adenosine is both a potent negative inotropic agent and 
a  coronary  vasodilator  (14).
    Taken together, cordycepin and adenosine must represent 
excellent  immunomodulators  regulating  immune  cell  activa-
tion  via  the  suppression  of  over-expressed  inflammation. 
However, the effects of neither cordycepin nor adenosine on 
morphological  change  in  macrophages  have  been  determi-
ned.
    In the current study, we investigated the effects of cordyce-
pin and adenosine on morphological changes in macrophage 
under  various  experimental  conditions.
MATERIALS AND METHODS
Reagents
Cordycepin, adenosine, lipopolysaccharide (LPS), and 3-(4,5- 
dimethylthiazol-2-yl)2,5-dephenyltetrazolium  bromide  (MTT) 
were purchased from Sigma (St. Louis, MS, USA). Dulbecco’s 
Modified Eagle Medium (DMEM), antibiotic-penicillin/strepto-
mycin solution, and fetal bovine serum (Hyclone, Logan, UT, 
USA)  were  used  for  cell  culture.
Cell culture
RAW 264.7 cells, a murine macrophage cell line, was main-
tained in a 95% air, 5% CO2 atmosphere in DMEM supple-
mented with 10% heat-inactivated fetal bovine serum (FBS), 
10,000  U/ml  penicillin,  and  10,000  U/ml  streptomycin.
Cytotoxicity assay
Cell viability was determined by a MTT reduction assay. In 
brief,  RAW  264.7  cells  were  pre-incubated  overnight  in 
24-well plates at a density of 2×10
5 cells per well, and were 
then washed with 1x PBS. Cells were then treated with differ-
ent concentrations of cordycepin or adenosine for 24 hrs and 
grown in 0.5 mg/ml MTT at 37
oC for 4 hrs. After removing 
culture supernatants, the resulting dark blue crystals were dis-
solved with DMSO (Dimethyl sulfoxide). Absorbance values 
were read at 560 nm using an automated VERSAmax micro-
plate reader (Molecular Devices, Sunnyvale, CA, USA). All de-
terminations were confirmed by replication in at least three 
independent  experiments.
Reverse transcription (RT)-PCR analysis
Total  RNA  was  prepared  from  cells  using  the  RNeasy  Mini 
kit (QIAGEN, Valencia, CA, USA) according to the protocol 
for the manufacturer. For RT-PCR, 1μg/ml of total RNA from 
each  sample  was  reverse  transcribed  for  1  hr  at  37
oC  in  a 
reaction  mixture  containing  2  mM  deoxynucleotide  triphos-
phate (dNTP), 2μM oligo-dT primer, 1x reverse transcriptase 
buffer, 200 units MMLV reverse transcriptase, and 1 U RNase 
inhibitor (invitrogen, Carlsbad, CA, USA). Next, PCR was per-
formed using the above-prepared cDNA as a template, with 
the following cycle parameters: 94
oC, 2 min; 35 cycles, 94
oC, 
45 s; 62
oC, 45 s, 72
oC, 1 min; 72
oC, 5 min, 4
oC, ∞. All PCR 
products were visualized by electrophoresis in 1.5% agarose 
gels, followed by straining with ethidium bromide (EtBr; 0.5
μg/ml).Verification of specific genes was established using 
their predicted sizes under ultraviolet (UV) light. The primer 
sequences were as follows: 5'-CAG GAT GAG GAC ATG ACA 
CC-3'  (forward),  5'-CTC  TGC  AGA  CTC  AAA  CTC  CAC-3' 
(reverse) for IL-1β; 5'-TGC TGG GTA CTT ACA AGG ACC-3' 
(forward), 5'-CAG AGC GGA TGA AGG TAA AGC-3' (reverse) 
for IL-1RA; 5'-TGG CCA CAC TTG AGA GCT GC-3' (forward), 
5'-TTC AGG GAT GAA GCG GCT GG-3' (reverse) for IL-10; 
5 ' - T T G  A C C  T C A  G C G  C T G  A G T  T A - 3 '  ( f o r w a r d ) ,  5 ' - C C T  
GTA GCC CAC GTC GTA GC-3' (reverse) for TNF-α; 5'-ATC 
ATC CTC ACT GCA GCC GC-3' (forward), 5'-CAC ACT TGG 
CGG TTC CTT CG-3' (reverse) for RANTES; 5'-TCC TGT CCG 
TCT TCT ACG CC-3' (forward), 5'-ATT GTG GAG GCC CTC 
ATG GC-3' (reverse) for CX3CR1; 5'-CTA AAC CAG GAG TCC 
TGC GG-3' (forward), 5'-CTA GTG GCC AAG GTG ATC CC-3' 
(reverse)  for  CX3CL1;  5'-GGA  GCT  GGT  GAA  ACG  GAA 
G C - 3 '  ( f o r w a r d ) ,  5 ' - C A T  A G T  A G T  C C G  C T T  C G G  G C - 3 '  
(reverse) for TGF-β; and 5'-GTG GGC CGC CCT AGG ACC 
AG-3' (forward), 5'-GGA GGA AGA GGA TGC GGC AG T-3' 
(reverse)  for  β-actin  as  an  internal  PCR  control.  Band  in-
tensity was quantified by densitometric analysis (Infinity 3026, 
Vilber  Lourmat,  Marne  la  Valled,  France).
Morphology
To determine the effects of cordycepin or adenosine on mac-
rophage morphology, cells were cultured in 24-well plates at 
a density of 2×10
5 cells per well, sterile for 24 hrs. The cul-Role of Cordycepin and Adenosine on the Phenotypic Switch of Macrophages
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ture medium was then removed, and the cells were treated 
with  (A)  cordycepin  (5,  10,  20,  40μg / m l )  i n  t h e  p r e s e n c e  
of LPS (100 ng/ml), and (B) adenosine (5, 10, 20, 40μg/ml) 
in the absence of LPS, for 24 hrs. Then, to investigate which 
combination of cordycepin and adenosine affected the phe-
notypic changes in macrophages, cells were treated with (C) 
adenosine  (2.5μg/ml)/cordycepin  (5μg/ml),  adenosine  (5 
μg/ml)/cordycepin (10μg/ml), adenosine (10μg/ml)/cordy-
cepin (20μg/ml), and adenosine (20μg/ml)/cordycepin (40
μg/ml),  (D)  adenosine  (20μg/ml)/cordycepin  (10μg/ml), 
adenosine (40μg/ml)/cordycepin (20μg/ml), and adenosine 
(80μg/ml)/cordycepin (40μg/ml), for 24 hrs. Following the 
t r e a t m e n t ,  t h e  c u l t u r e  s u p e r n a t a n t  w a s  r e m o v e d  a n d  c e l l s  
were  then  fixed  and  stained  in  Diff-quick  Solution  (Baxter, 
Houston, TX, USA). Also, to determined the effects of cordy-
c ep in  on  li pid  ac c um u lat io n ,  ce ll s w er e c u lt ur ed  in  2 4- w el l 
plates at a density of 2×10
5 cells per well, sterile for 24 hrs. 
The culture medium was removed, and the cells were treated 
with cordycepin (5, 10, 20, 40μg/ml) in the presence of LPS 
(100 ng/ml) for 24 hrs. Following the treatment, the culture 
supernatant  was  removed  and  cells  were  then  fixed  and 
stained  in  Oil  red  O  solution.
Statistical analysis
Data  are  expressed  as  mean±standard  deviation.  Statistical 
significance  between  the  groups  was  determined  by  paired 
t-test  and  one-way  ANOVA  for  repeated  measures.  Results 
with  p＜0.05  were  considered  statistically  significant.  Data 
were assessed using SPSS (Version 15.0, SPSS Inc., Chicago, 
IL,  USA).
RESULTS
Effect of cordycepin and adenosine on cell viability 
To rule  out cordycepin  toxicity, we tested  its  effect  on  the 
viability of RAW 264.7 by MTT assay. Exposure of cells to 
cordycepin (5∼40μg/ml) or adenosine (2.5∼40μg/ml) for 
24 hrs showed no significant toxic adverse effects on viability 
compare  to  the  untreated  controls  (Supplementary  Fig.  1).
Cordycepin- and adenosine-induced morphologi-
cal changes of macrophages
Morphological  examination  under  a  light  microscope  in-
dicated that more than half of the macrophages appeared as-
teroid and there were little or no phagocytic granules prior 
to treatment with cordycepin or ademosine. After being treat-
ed  with  cordycepin  (5∼40μg/ml)  in  the  presence  of  LPS 
(100  ng/ml),  macrophages  in  the  control  group  became 
round  and  the  granules  increased  (Fig.  1A)  whereas  those 
without adenosine and LPS appeared larger and rougher than 
control  (Fig.  1B).  These  results  suggested  that  cells  treated 
with high concentration of adenosine (40μg/ml) were similar 
to  those  exposed  to  LPS.  However,  cells  treated  with  high 
concentrations of cordycepin (40μg/ml) in the presence with 
LPS  were  smoother  than  those  treated  with  LPS.
Effects of cordycepin and adenosine on the gene 
expression of M1 cytokines and chemokines
To further investigate to important role of cordycepin and ad-
enosine on inflammation, murine macrophage cells with cor-
dycepin (5∼40μg/ml) in the presence of LPS (100 ng/ml), 
or adenosine (10μg/ml) in the absence with LPS, for 24 hrs 
exhibited altered M1 cytokines and chemokines. Cordycepin 
suppressed  IL-1β,  TNF-α,  CX3CR1,  CX3CL1,  and  RANTES 
expression in a dose-dependent manner. Adenosine exhibited 
a  slight  increase  in  these  genes,  while  the  cells  co-treated 
with adenosine and LPS decreased their expression (Fig. 2).
Effects of cordycepin and adenosine on the gene 
expression of M2 cytokines
We determined M2 cytokines expression on inflammation in 
murine macrophage cells with cordycepin (5∼40μg/ml) in 
the presence of LPS (100 ng/ml) or adenosine (10μg/ml) in 
the  absence  with  LPS,  for  24  hrs.  Cordycepin  upregulated 
IL-10 and TGF-β expression in a dose-dependent manner. 
Adenosine increased the expression of these genes in a man-
n e r  s i m i l a r  t o  t h a t  o f  L P S  ( F i g .  3 ) .
Phenotypic switch by cordycepin with adenosine or 
adenosine with cordycepin
When  cultured  in  medium  alone,  normal  RAW  264.7  cells 
tended to be round, with none appearing to spread over the 
surface (Fig. 4). In cells treated with double the concentration 
of cordycepin than adenosine, a naïve macrophage form from 
the M1 phenotype was induced (Fig. 4A). On the other hand, 
in cells treated with double the concentration of adenosine 
than  cordycepin, an  M2 phenotype from  an M1  phenotype 
was  induced  (Fig.  4B).
Lipid accumulation in macrophages
When cultured in medium alone, normal RAW 264.7 cells tend-
ed  to  be  round,  with  none  appearing  to  spread  over  the Role of Cordycepin and Adenosine on the Phenotypic Switch of Macrophages
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Figure 1. RAW 264.7 cells were cultured on cover slips in the presence of various concentrations of cordycepin (A) medium alone (a), LPS 
100 ng/ml (b), cordycepin (5μg/ml) (c), 10μg/ml (d), 20μg/ml (e), and 40μg/ml (f), in the presence of LPS and adenosine (B) medium alone
(a), LPS 100 ng/ml (b), adenosine (5μg/ml) (c), 10μg/ml (d), 20μg/ml (e), 40μg/ml (f), and in the absence of LPS for 24 hrs. The cells were
then fixed and stained in Diff-quick Solution (×400).
surface. The cells treated with a high concentration of cordyce-
pin exhibited an increased accumulation of red-stained lipids 
as compared to those treated with low concentrations (Fig. 5).
DISCUSSION
The  data  presented  in  this  paper  indicates  that  cordycepin Role of Cordycepin and Adenosine on the Phenotypic Switch of Macrophages
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Figure 2. Effects of cordycepin and adenosine on the expression of M1 cytokines (A, B), chemokines, and their receptor (C, D) in RAW 264.7
cells. Cells were incubated in various concentrations of cordycepin (5, 10, 20, 40μg/ml) in the presence of LPS (100 ng/ml) or adenosine (10μg/ml),
in the presence or absence of LPS, for 24 hrs. mRNA levels of M1 cytokine and chemokine genes were determined by RT-PCR analysis. β-actin
was used as a control. 
††p＜0.01 vs. cells only; *p＜0.05, **p＜0.01 vs. LPS only; and 
†p＜0.05 vs. cells only were all based on Student’s
t-tests.
and adenosine regulate immune responses. The present study 
demonstrated  that  cordycepin  and  adenosine  changed  the 
m a c r o p h a g e  p h e n o t y p i c  s w i t c h  v i a  a  d e c r e a s e  i n  t h e  e x -
pression of pro-inflammatory cytokines and chemokines (IL-1
β, IL-6, TNF-α, RANTES, CX3CL1), and an induction of an-
ti-inflammatory cytokine (IL-1ra, IL-10, TGF-β) in RAW 264.7 
cells.
    In inflamed tissue or lesions, naïve macrophages are acti-
vated either classically or alternatively depending on the pro-
file of the environmental stimuli. Classically activated macro-
phages (M1), induced by IFN-γ plus TNF-α or TLRs ligands, 
are typical effectors of cell-mediated immunity. Alternative ac-
tivation of macrophages by IL-4 and IL-13 or by phagocytosis 
of apoptotic cells antagonizes classical activation. Alternatively 
activated macrophages (M2) secrete the anti-inflammatory cy-
tokines IL-1ra, IL-10, and TGF-β, thereby providing signals 
to  deactivate  macrophages  as  well  as  to  mediate  im-
munosuppressive and healing processes. The phenotypes of 
both M1 and M2 cells in inflamed tissues is the major source 
of cytokines, and it is believed that the coordinated switching 
between  these  two  phenotypes  determines  the  outcome  of 
i n f l a m m a t o r y  p r o c e s s e s  ( 1 5 ) .  These  cytokines  affect  wound 
healing rate and wound-breaking strength while M1 cells pro-
duce  pro-inflammatory  cytokines  and  chemokines,  IL-1β, 
IL-6, TNF-α, RANTES, and CX3CL1, and attract more atten-
tion in that they can be localized to the infected tissue, man-
ifested  systemically  throughout  the  body,  and  cause  vaso-
dilation as well as symptoms of inflammation, such as red-
ness, swelling, heat, and pain (16). Cordycepin down-regu-
lated the expression of pro-inflammatory molecules such as Role of Cordycepin and Adenosine on the Phenotypic Switch of Macrophages
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Figure 2. Continued.
IL-1β  and  TNF-α,  and  the  chemokines,  CX3CR1  and 
RANTES, in LPS-stimulated RAW 264.7 cells (Fig. 2). When 
we examined the morphological changes that took place in 
macrophages treated with cordycepin and LPS, cells treated 
with LPS and low concentrations of cordycepin (5∼10μg/ml) 
w e r e  s i m i l a r  t h o s e  e x p o s e d  t o  L P S  a l o n e .  H o w e v e r ,  c e l l s  
treated with high concentrations of cordycepin (40μg/ml) in 
combination with LPS were smoother than those treated with 
LPS alone (Fig. 1A). Also, these levels inhibited the activation 
of pro-inflammatory cytokines and related proteins in both of 
the  LPS-activated  cell  types  (17,18).
    Adenosine treated with LPS down-regulated the expression Role of Cordycepin and Adenosine on the Phenotypic Switch of Macrophages
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Figure 3. Effects of cordycepin (A) and adenosine (B) on the expression of M2 cytokines in RAW 264.7 cells. Cells were incubated in various
concentrations of cordycepin (5, 10, 20, 40μg/ml) in the presence of LPS (100 ng/ml), or adenosine (10μg/ml), in the presence or absence 
of LPS, for 24 hrs. mRNA levels of M2 cytokine genes were determined by RT-PCR analysis. β-actin was used as a control. 
††p＜0.01 vs.
cells only; *p＜0.05, **p＜0.01 vs. LPS only; and 
†p＜0.01 vs. cells only were based on Student’s t-tests.
of  pro-inflammatory  cytokines  and  chemokines;  however, 
when  we exposed them to adenosine,  it induced gene  ex-
pression  in  macrophages  somewhat  (Fig.  2).  Additionally, 
with respect to morphological change, low concentrations of 
adenosine activated macrophages and high concentration of 
adenosine  induced  M2  cells  that  contained  lipid  vacuoles Role of Cordycepin and Adenosine on the Phenotypic Switch of Macrophages
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Figure 4. The morphological switch by cordycepin with adenosine or adenosine and cordycepin. RAW 264.7 cells were cultured on cover slips
in the presence of double the concentration of cordycepin than adenosine (A) in: medium alone (a), LPS 100 ng/ml (b), adenosine (2.5μg/ml)/
cordycepin (5μg/ml) (c), adenosine (5μg/ml)/cordycepin (10μg/ml) (d), adenosine (10μg/ml)/cordycepin (20μg/ml) (e), adenosine (20μg/ml)/ 
cordycepin (40μg/ml) (f), and 2x adenosine/cordycepin (B) in: medium alone (a), LPS 100 ng/ml (b), adenosine (20μg/ml)/cordycepin (10μg/ml)
(c), adenosine (40μg/ml)/cordycepin (20μg/ml) (d), adenosine (80μg/ml)/cordycepin (40μg/ml) (e), for 24 hrs. The cells were then fixed and
stained in Diff-quick Solution (×400).Role of Cordycepin and Adenosine on the Phenotypic Switch of Macrophages
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Figure 5. Lipid accumulation of macrophages by cordycepin. RAW 264.7 cells were cultured on cover slips in the presence of various 
concentrations of cordycepin: medium alone (A), LPS (100 ng/ml) (B), cordycepin (5μg/ml) (C), 10μg/ml (D), 20μg/ml (E), 40μg/ml (F) in
the presence of LPS, for 24 hrs. The cells were then fixed and stained in oil red O solution. (×400).
(Fig.  1B  and  Fig.  5).
    In contrast, Macrophages secreted anti-inflammatory cyto-
kines after treatment with cordycepin or adenosine (Fig. 3), 
which differentiated M2 macrophages (Fig. 1). M2 macropha-
ges are generally characterized by low production of pro-in-
flammatory cytokines and high expression of anti-inflamma-
tory mediators such as IL-1ra, IL-10, and TGF-β (Fig. 3). Fur-
ther  research  will  be  needed  to  examine  IL-1ra  expression 
which  was  down-regulated  by  cordycepin  (Fig.  3A)  versus 
adenosine, which showed an up-regulation of anti-inflamma-
tory cytokines (Fig. 3B). Cells treated with both cordycepin 
and adenosine still induced the M2 phenotype from the phe-
notype of macrophages when treated with LPS only (Fig. 4).
    The purpose of this study was to investigate the effects of 
the main constituents of Cordyceps militaris, cordycepin and 
adenosine, on macrophage maturation/differentiation and cy-
tokine production as well as to determine how the immune 
responses are modulated in inflammatory diseases. We dem-
onstrated that both cordycepin and adenosine were able to 
regulate  immune  responses  by  producing  anti-inflammatory 
cytokines and also showed the phenotypic switch from M1 
to M2 in macrophages. Treatment with both cordycepin and 
adenosine in LPS-activated macrophages was examined and 
resulted  in  a  down-regulation  of  M1  cytokines  and  chemo-
kines and alternatively, an up-regulation of M2 cytokines in 
macrophages.
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